Evidence map›Paper›PMID 36678649›Full record

ArticlePharmaceutics2022

Bioadhesive 3D-Printed Skin Drug Delivery Polymeric Films: From the Drug Loading in Mesoporous Silica to the Manufacturing Process.

Rafaela Santos de Oliveira, Nadine Lysyk Funk, Juliana Dos Santos, Thayse Viana de Oliveira, Edilene Gadelha de Oliveira, Cesar Liberato Petzhold, Tania Maria Haas Costa, Edilson Valmir Benvenutti, Monique Deon, Ruy Carlos Ruver Beck

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Rafaela Santos de OliveiraPrograma de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90610-900, Brazil.
Nadine Lysyk FunkPrograma de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90610-900, Brazil.
Juliana Dos SantosPrograma de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90610-900, Brazil.ORCID 0000-0001-9274-264X
Thayse Viana de OliveiraPrograma de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90610-900, Brazil.
Edilene Gadelha de OliveiraPrograma de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90610-900, Brazil.
Cesar Liberato PetzholdInstituto de Química, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90650-001, Brazil.ORCID 0000-0002-5919-8133
Tania Maria Haas CostaInstituto de Química, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90650-001, Brazil.
Edilson Valmir BenvenuttiInstituto de Química, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90650-001, Brazil.
Monique DeonDepartamento de Farmacociências, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS 90050-170, Brazil.ORCID 0000-0002-9889-7420
Ruy Carlos Ruver BeckPrograma de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90610-900, Brazil.ORCID 0000-0001-6262-1097
Universidade Federal do Rio Grande do Sul · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior Finance Code 001Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul 21/2551-0002007-5National Council for Scientific and Technological Development 422698/2018-0
6 · The paper itself

Abstract

The alliance between 3D printing and nanomaterials brings versatile properties to pharmaceuticals, but few studies have explored this approach in the development of skin delivery formulations. In this study, clobetasol propionate (CP) was loaded (about 25%

Indexed as

3D printingclobetasol propionatedrugmesoporous silicananomaterialsemisolid extrusion

Identifiers

PMID36678649
PMCPMC9861290
OpenAlexW4313469580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.